Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Scientific Reports|October 22, 2021
Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancementJurij Rosen, Gabriele Stoffels, Philipp Lohmann, et al.
European Radiology|November 18, 2016
Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase 18F-FET PET accuracy without dynamic scansPhilipp Lohmann, Gabriele Stoffels, Garry Ceccon, et al.
Lancet (London, England)|October 11, 2014
Self-reported quality of life of adolescents with cerebral palsy: a cross-sectional and longitudinal analysisAllan Colver, Marion Rapp, Nora Eisemann, et al.
BMC Health Services Research|July 7, 2018
Quality of health care in adolescents and adults with disorders/differences of sex development (DSD) in six European countries (dsd-LIFE)Ute Thyen, Till Ittermann, Steffen Flessa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 13, 2012
Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of gliomaMarion Rapp, Alexander Heinzel, Norbert Galldiks, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 14, 2014
European study of frequency of participation of adolescents with and without cerebral palsySusan I Michelsen, Esben M Flachs, Mogens T Damsgaard, et al.
Journal of Pediatric Urology|December 28, 2020
Self- and proxy-reported outcomes after surgery in people with disorders/differences of sex development (DSD) in Europe (dsd-LIFE)Marion Rapp, Lise Duranteau, Tim C van de Grift, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Treatment-Related Uptake of O-(2-18F-Fluoroethyl)-l-Tyrosine and l-[Methyl-3H]-Methionine After Tumor Resection in Rat Glioma ModelsStefanie Geisler, Carina Stegmayr, Nicole Niemitz, et al.
Neuro-Oncology|May 27, 2015
The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent gliomaNorbert Galldiks, Gabriele Stoffels, Christian Filss, et al.
Neuro-Oncology|January 1, 2017
The use of O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of gliomas located in the brainstem and spinal cordCaroline Tscherpel, Veronika Dunkl, Garry Ceccon, et al.
Pageof 13